Options Brief: Questcor Pharmaceuticals (QCOR)

QCOR – Questcor Pharmaceuticals, Inc. – Call options on the specialty pharmaceutical company engaged in providing prescription drugs for central nervous system disorders are active this afternoon with shares of the underlying stock trading 6.12% higher on the day at a new 52-week high of $10.05. Investors trafficking Questcor options honed in on the June $12.5 strike, exchanging more than 7,670 calls there by 12:50 pm (ET), versus previously existing open interest of just 746 contracts at that strike. It looks like the majority of the calls were purchased at an average premium of $0.21 per contract. Call buyers are prepared to make money should Questcor’s shares jump 26.45% in the next several weeks to surpass the average breakeven price of $21.71 by expiration.

About Andrew Wilkinson 1023 Articles

Affiliation: Interactive Brokers

Andrew Wilkinson is the senior market analyst at Interactive Brokers Group, where he provides daily commentary and analysis on U.S. equity options trading throughout the trading day. Andrew provides webinars designed to explain option-related trading scenarios covering futures, fixed income, forex and equities.

Interactive Brokers: Interactive Brokers offers direct market access to around 80 electronic global markets from a single account. Successful traders and investors understand that superior technology and lower trading costs can result in greater returns. For 32 years we have been building direct access trading technology that delivers real advantages to professionals worldwide. With consolidated equity capital of US $4.4 billion, IB and its affiliates exceed 1,000,000 trades per day. In addition, our prudent and conservative risk policies make Interactive Brokers a safe haven for your money. Discover some of the reasons why IB, the largest independent US broker/dealer, is the professional traders' and investors' choice.

Visit: Interactive Brokers

Be the first to comment

Leave a Reply

Your email address will not be published.